GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2017. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,048,000 | -64.2% | 59,113 | -69.7% | 0.01% | -61.3% |
| Q4 2021 | $5,718,000 | -46.4% | 195,366 | -53.3% | 0.03% | -55.1% |
| Q3 2021 | $10,665,000 | -11.3% | 418,563 | +22.0% | 0.07% | -16.9% |
| Q2 2021 | $12,018,000 | +3.5% | 343,176 | +20.4% | 0.08% | -2.4% |
| Q1 2021 | $11,612,000 | -21.5% | 284,955 | -16.6% | 0.08% | -31.5% |
| Q4 2020 | $14,794,000 | +796.6% | 341,583 | +1041.4% | 0.12% | +785.7% |
| Q3 2020 | $1,650,000 | -46.0% | 29,926 | -22.1% | 0.01% | -76.7% |
| Q4 2019 | $3,054,000 | +63.0% | 38,423 | -1.0% | 0.06% | +36.4% |
| Q1 2018 | $1,874,000 | -43.9% | 38,806 | -57.2% | 0.04% | -45.7% |
| Q1 2017 | $3,341,000 | – | 90,655 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |